← FDA DRUG APPROVALS

FDA ANDA · ANDA077298

METOPROLOL SUCCINATE

Sponsor: ACTAVIS LABS FL INC

APPLICATION
ANDA077298
TYPE
ANDA
ORIGINAL APPROVAL
2010-04-15
LATEST ACTION
2015-06-29
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 100MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 200MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL

Approval history

2015-06-29Labeling · Supplement 16 · standardAP
2013-05-31Labeling · Supplement 1AP
2010-04-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →